Ngā hua rapu kaituhi

1

Designer Arrays for Defined Mutant Analysis To Detect Genes Essential for Survival of Mycobacterium tuberculosis in Mouse Lungs mā Lamichhane, Gyanu, Tyagi, Sandeep, Bishai, William R.

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model mā Gupta, Shashank, Tyagi, Sandeep, Bishai, William R.

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Characterization of the Mycobacterium tuberculosis Sigma Factor SigM by Assessment of Virulence and Identification of SigM-Dependent Genes mā Agarwal, Nisheeth, Woolwine, Samuel C., Tyagi, Sandeep, Bishai, William R.

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis mā Tasneen, Rokeya, Tyagi, Sandeep, Williams, Kathy, Grosset, Jacques, Nuermberger, Eric

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis mā Almeida, Deepak, Nuermberger, Eric, Tyagi, Sandeep, Bishai, William R., Grosset, Jacques

I whakaputaina 2007

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases mā Tyagi, Sandeep, Gupta, Paras, Saini, Arminder Singh, Kaushal, Chaitnya, Sharma, Saurabh

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Bactericidal Activity of Increasing Daily and Weekly Doses of Moxifloxacin in Murine Tuberculosis mā Yoshimatsu, Tetsuyuki, Nuermberger, Eric, Tyagi, Sandeep, Chaisson, Richard, Bishai, William, Grosset, Jacques

I whakaputaina 2002

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay mā Converse, Paul J., Almeida, Deepak V., Tyagi, Sandeep, Xu, Jian, Nuermberger, Eric L.

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Use of blood components in critically ill patients in the medical intensive care unit of a tertiary care hospital mā Makroo, R N, Mani, R. K., Vimarsh, Raina, Kansal, Sudha, Pushkar, Kumar, Tyagi, Sandeep

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis mā Tyagi, Sandeep, Nuermberger, E., Yoshimatsu, T., Williams, K., Rosenthal, I., Lounis, N., Bishai, W., Grosset, J.

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Rifapentine, Moxifloxacin, or DNA Vaccine Improves Treatment of Latent Tuberculosis in a Mouse Model mā Nuermberger, Eric, Tyagi, Sandeep, Williams, Kathy N., Rosenthal, Ian, Bishai, William R., Grosset, Jacques H.

I whakaputaina 2005

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens with or without Continuation of Pyrazinamide in Murine Tuberculosis mā Ahmad, Zahoor, Tyagi, Sandeep, Minkowski, Austin, Peloquin, Charles A., Grosset, Jacques H., Nuermberger, Eric L.

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis mā Nuermberger, Eric, Tyagi, Sandeep, Tasneen, Rokeya, Williams, Kathy N., Almeida, Deepak, Rosenthal, Ian, Grosset, Jacques H.

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis mā Almeida, Deepak, Nuermberger, Eric, Tasneen, Rokeya, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy, Peloquin, Charles, Grosset, Jacques

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy mā Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor mā Gupta, Shashank, Tyagi, Sandeep, Almeida, Deepak V., Maiga, Mariama C., Ammerman, Nicole C., Bishai, William R.

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations mā Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies mā Zhang, Nan, Strydom, Natasha, Tyagi, Sandeep, Soni, Heena, Tasneen, Rokeya, Nuermberger, Eric L., Savic, Rada M.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease mā Almeida, Deepak V., Converse, Paul J., Li, Si-Yang, Tyagi, Sandeep, Nuermberger, Eric L., Grosset, Jacques H.

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis mā Li, Si-Yang, Tasneen, Rokeya, Tyagi, Sandeep, Soni, Heena, Converse, Paul J., Mdluli, Khisimuzi, Nuermberger, Eric L.

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Tyagi, Sandeep

Designer Arrays for Defined Mutant Analysis To Detect Genes Essential for Survival of Mycobacterium tuberculosis in Mouse Lungs mā Lamichhane, Gyanu, Tyagi, Sandeep, Bishai, William R.

Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model mā Gupta, Shashank, Tyagi, Sandeep, Bishai, William R.

Characterization of the Mycobacterium tuberculosis Sigma Factor SigM by Assessment of Virulence and Identification of SigM-Dependent Genes mā Agarwal, Nisheeth, Woolwine, Samuel C., Tyagi, Sandeep, Bishai, William R.

Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis mā Tasneen, Rokeya, Tyagi, Sandeep, Williams, Kathy, Grosset, Jacques, Nuermberger, Eric

In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis mā Almeida, Deepak, Nuermberger, Eric, Tyagi, Sandeep, Bishai, William R., Grosset, Jacques

The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases mā Tyagi, Sandeep, Gupta, Paras, Saini, Arminder Singh, Kaushal, Chaitnya, Sharma, Saurabh

Bactericidal Activity of Increasing Daily and Weekly Doses of Moxifloxacin in Murine Tuberculosis mā Yoshimatsu, Tetsuyuki, Nuermberger, Eric, Tyagi, Sandeep, Chaisson, Richard, Bishai, William, Grosset, Jacques

Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay mā Converse, Paul J., Almeida, Deepak V., Tyagi, Sandeep, Xu, Jian, Nuermberger, Eric L.

Use of blood components in critically ill patients in the medical intensive care unit of a tertiary care hospital mā Makroo, R N, Mani, R. K., Vimarsh, Raina, Kansal, Sudha, Pushkar, Kumar, Tyagi, Sandeep

Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis mā Tyagi, Sandeep, Nuermberger, E., Yoshimatsu, T., Williams, K., Rosenthal, I., Lounis, N., Bishai, W., Grosset, J.

Rifapentine, Moxifloxacin, or DNA Vaccine Improves Treatment of Latent Tuberculosis in a Mouse Model mā Nuermberger, Eric, Tyagi, Sandeep, Williams, Kathy N., Rosenthal, Ian, Bishai, William R., Grosset, Jacques H.

Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens with or without Continuation of Pyrazinamide in Murine Tuberculosis mā Ahmad, Zahoor, Tyagi, Sandeep, Minkowski, Austin, Peloquin, Charles A., Grosset, Jacques H., Nuermberger, Eric L.

Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis mā Nuermberger, Eric, Tyagi, Sandeep, Tasneen, Rokeya, Williams, Kathy N., Almeida, Deepak, Rosenthal, Ian, Grosset, Jacques H.

Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis mā Almeida, Deepak, Nuermberger, Eric, Tasneen, Rokeya, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy, Peloquin, Charles, Grosset, Jacques

Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy mā Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.

Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor mā Gupta, Shashank, Tyagi, Sandeep, Almeida, Deepak V., Maiga, Mariama C., Ammerman, Nicole C., Bishai, William R.

Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations mā Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies mā Zhang, Nan, Strydom, Natasha, Tyagi, Sandeep, Soni, Heena, Tasneen, Rokeya, Nuermberger, Eric L., Savic, Rada M.

Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease mā Almeida, Deepak V., Converse, Paul J., Li, Si-Yang, Tyagi, Sandeep, Nuermberger, Eric L., Grosset, Jacques H.

Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis mā Li, Si-Yang, Tasneen, Rokeya, Tyagi, Sandeep, Soni, Heena, Converse, Paul J., Mdluli, Khisimuzi, Nuermberger, Eric L.

Ngā utauta rapu:

Ngā marau whai pānga